151 related articles for article (PubMed ID: 16681393)
1. Localization of multidrug transporter substrates within model membranes.
Siarheyeva A; Lopez JJ; Glaubitz C
Biochemistry; 2006 May; 45(19):6203-11. PubMed ID: 16681393
[TBL] [Abstract][Full Text] [Related]
2. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.
Eckford PD; Sharom FJ
Biochemistry; 2008 Dec; 47(51):13686-98. PubMed ID: 19049391
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein (ABCB1) interacts directly with lipid-based anti-cancer drugs and platelet-activating factors.
Eckford PD; Sharom FJ
Biochem Cell Biol; 2006 Dec; 84(6):1022-33. PubMed ID: 17215888
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells.
Chen Y; Pant AC; Simon SM
Cancer Res; 2001 Nov; 61(21):7763-9. PubMed ID: 11691790
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane aromatic amino acid distribution in P-glycoprotein. A functional role in broad substrate specificity.
Pawagi AB; Wang J; Silverman M; Reithmeier RA; Deber CM
J Mol Biol; 1994 Jan; 235(2):554-64. PubMed ID: 7904655
[TBL] [Abstract][Full Text] [Related]
7. The P-glycoprotein multidrug transporter.
Sharom FJ
Essays Biochem; 2011 Sep; 50(1):161-78. PubMed ID: 21967057
[TBL] [Abstract][Full Text] [Related]
8. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites.
Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J
Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072
[TBL] [Abstract][Full Text] [Related]
9. The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids.
Eckford PD; Sharom FJ
Biochem J; 2005 Jul; 389(Pt 2):517-26. PubMed ID: 15799713
[TBL] [Abstract][Full Text] [Related]
10. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
11. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
12. Influence of perfluorinated compounds on the properties of model lipid membranes.
Matyszewska D; Tappura K; Orädd G; Bilewicz R
J Phys Chem B; 2007 Aug; 111(33):9908-18. PubMed ID: 17672485
[TBL] [Abstract][Full Text] [Related]
13. Molecular docking characterizes substrate-binding sites and efflux modulation mechanisms within P-glycoprotein.
Ferreira RJ; Ferreira MJ; dos Santos DJ
J Chem Inf Model; 2013 Jul; 53(7):1747-60. PubMed ID: 23802684
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of multidrug resistance in relation to passive membrane permeation.
Eytan GD
Biomed Pharmacother; 2005 Apr; 59(3):90-7. PubMed ID: 15795101
[TBL] [Abstract][Full Text] [Related]
15. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
[TBL] [Abstract][Full Text] [Related]
16. Membrane topology of a 14-mer model amphipathic peptide: a solid-state NMR spectroscopy study.
Ouellet M; Doucet JD; Voyer N; Auger M
Biochemistry; 2007 Jun; 46(22):6597-606. PubMed ID: 17487978
[TBL] [Abstract][Full Text] [Related]
17. A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR.
Cianchetta G; Singleton RW; Zhang M; Wildgoose M; Giesing D; Fravolini A; Cruciani G; Vaz RJ
J Med Chem; 2005 Apr; 48(8):2927-35. PubMed ID: 15828831
[TBL] [Abstract][Full Text] [Related]
18. An ABC-type multidrug transporter of Lactococcus lactis possesses an exceptionally broad substrate specificity.
Poelarends GJ; Mazurkiewicz P; Putman M; Cool RH; Veen HW; Konings WN
Drug Resist Updat; 2000 Dec; 3(6):330-334. PubMed ID: 11498401
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and pharmacological properties of an allosteric modulator site of the human P-glycoprotein (ABCB1).
Maki N; Dey S
Biochem Pharmacol; 2006 Jul; 72(2):145-55. PubMed ID: 16729976
[TBL] [Abstract][Full Text] [Related]
20. Several major antiepileptic drugs are substrates for human P-glycoprotein.
Luna-Tortós C; Fedrowitz M; Löscher W
Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
